Zatorowość plucna w przebiegu raka żolądka

Abstract

Author(s): Ziólkowska Ewa, Biedka Marta,Wiśniewski Tomasz, Makarewicz Adrianna, Makarewicz Roman, Żmuda Elżbieta

The prevalence of clinically apparent venous thromboembolism (VTE) of up to 15% across all cancer patients and over 50% of palliative care inpatients. Acute pulmonary embolism (PE) is a relatively common event with a wide spectrum of clinical presentation that ranges from small asymptomatic and incidentally detected subsegmental to massive PE that can causes death. Acute pulmonary embolism is common in patients with any cancer and the incidence is increased by surgery, chemotherapy, radiotherapy and disease progression. Chemotherapeutic agents may also contribute to hypercoagulability by enhancing the release of procoagulants and cytokines from tumour cells, producing toxic substances, that can damage the endothelium, and reducing levels of natural anticoagulants. Thus the aim of our work is to present the case of a stomach cancer patient who experienced pulmonary embolus during radiochemotherapy as a adjuvant oncological treatment.

Share this article